Yonsei University
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2011-02-28
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 46
- Registration Number
- NCT00625937
- Locations
- 🇰🇷
Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of
Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2012-05-08
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 72
- Registration Number
- NCT00625560
- Locations
- 🇰🇷
Pusan National University School of Medicine, Busan, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2012-05-08
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 72
- Registration Number
- NCT00625339
- Locations
- 🇰🇷
Pusan National University School of Medicine, Busan, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 35
- Registration Number
- NCT00616499
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Conditions
- Lung Cancer
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 41
- Registration Number
- NCT00616785
- Locations
- 🇰🇷
Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of
Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion
- Conditions
- Macular EdemaBranch Retinal Vein Occlusion
- Interventions
- Procedure: Arteriovenous Crossing SheathotomyProcedure: Intravitreal Triamcinolone Acetonide Injection
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2008-02-11
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 40
- Registration Number
- NCT00612261
- Locations
- 🇰🇷
Yonsei University Health System, Seoul, Korea, Republic of
Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes
- Conditions
- Kidney TransplantationInsulin ResistanceAtherosclerosis
- Interventions
- First Posted Date
- 2008-01-18
- Last Posted Date
- 2008-01-18
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 83
- Registration Number
- NCT00598013
- Locations
- 🇰🇷
Yonsei University College of Medicine, Seoul, Korea, Republic of
Corneal Thinning During Topical Bevacizumab Therapy
- Conditions
- Corneal Neovascularization
- First Posted Date
- 2007-08-14
- Last Posted Date
- 2015-05-01
- Lead Sponsor
- Yonsei University
- Registration Number
- NCT00515684
- Locations
- 🇰🇷
Severance hospital, Seoul, Korea, Republic of
Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan
- Conditions
- Colorectal Cancer
- First Posted Date
- 2007-07-04
- Last Posted Date
- 2009-08-21
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 56
- Registration Number
- NCT00496704
- Locations
- 🇰🇷
Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of
Diurnal Intraocular Pressure and Peripapillary Retinal Blood Flow in Medically Controlled Open-Angle Glaucoma
- Conditions
- Open-Angle Glaucoma
- First Posted Date
- 2007-06-01
- Last Posted Date
- 2007-06-01
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 70
- Registration Number
- NCT00481208
- Locations
- 🇰🇷
Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of